ACET Quote, Trading Chart, Aceto Corporation

$11.75 Last:

-1.34% Change Percent:

$11.84 Open:

$11.75 Previous Close:

$12.06 High:

$11.66 Low:

65,743 Volume:

06/11/2021 04:42:15 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2021-06-11	11.84	11.75	12.06	11.66	65,743
2021-06-10	12.42	11.91	12.57	11.67	83,246
2021-06-09	12	12.28	12.64	12	95,401
2021-06-08	11.52	12	12.03	11.45	143,817
2021-06-07	12.31	11.51	12.31	11.42	232,973
2021-06-04	12.38	12.27	12.415	11.95	81,882
2021-06-03	12.31	12.24	12.825	11.5601	185,172
2021-06-02	12.41	12.47	13.12	12.31	83,131
2021-06-01	13.37	12.39	13.38	12.3	119,254
2021-05-31	13.17	13.42	13.65	13.1059	56,787
2021-05-28	13.17	13.42	13.65	13.1059	56,787
2021-05-27	13.7	13.12	13.74	12.92	72,512
2021-05-26	13.72	13.75	13.83	13.32	89,510
2021-05-25	14.43	13.89	14.43	13.71	64,208
2021-05-24	14.52	14.27	14.71	13.8	53,532
2021-05-21	15.05	14.46	15.05	14.17	138,662
2021-05-20	13.78	14.6	14.6	13.78	49,314
2021-05-19	13.25	13.73	13.89	12.65	80,314
2021-05-18	13.43	13.62	14.3199	13.3	80,762
2021-05-17	13.18	13.18	13.51	12.641	66,759

Stock Information

Aceto Corporation Company Name:

ACET Stock Symbol:

NASDAQ Market:

Aceto Corporation Website:

Get ACET Alerts

News, Short Squeeze, Breakout and More Instantly...

ACET - Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates

Initiated Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymphoma (NHL), interim clinical data expected in late 2021 Successfully raised $143.8 million in net proceeds through a public offering and concurrent private placement to advance a pipeline of CAR...
ACET - Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit

MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer, will pres...
ACET - Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer, will be p...